Jo Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 24-07-2024
- Paid Up Capital ₹ 3.70 Cr
as on 24-07-2024
- Company Age 9 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.42 Cr
as on 24-07-2024
- Satisfied Charges ₹ 9.10 Cr
as on 24-07-2024
- Revenue 18.38%
(FY 2023)
- Profit 36.61%
(FY 2023)
- Ebitda 77.24%
(FY 2023)
- Net Worth 34.77%
(FY 2023)
- Total Assets -23.10%
(FY 2023)
About Jo Pharma
The Corporate was formerly known as Jindal Omran Pharma Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 3.70 Cr.
The company currently has active open charges totaling ₹12.42 Cr. The company has closed loans amounting to ₹9.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakshit Jindal and Ankit Jindal serve as directors at the Company.
- CIN/LLPIN
U23109DL2015PTC288456
- Company No.
288456
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Jo Pharma Private Limited offer?
Jo Pharma Private Limited offers a wide range of products and services, including Home Appliances & Kitchen Appliances, Kitchen Appliance, Electric Kettle, Cookware and Cooking Utensils, Cooking Accessories, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Face Mask & Medical PPE Kits, Face Mask, Electric Cooker.
Who are the key members and board of directors at Jo Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakshit Jindal  | Director | 12-Dec-2015 | Current |
| Ankit Jindal | Director | 12-Dec-2015 | Current |
Financial Performance of Jo Pharma.
Jo Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.38% increase. The company also saw a substantial improvement in profitability, with a 36.61% increase in profit. The company's net worth Soared by an impressive increase of 34.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jo Pharma?
In 2023, Jo Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seoul Industries Private LimitedActive 6 years 6 monthsRakshit Jindal and Ankit Jindal are mutual person
Jr Jindal Infraprojects Private LimitedActive 12 years 6 monthsRakshit Jindal and Ankit Jindal are mutual person
Jindal Zein Ventures Private LimitedActive 8 years 8 monthsRakshit Jindal and Ankit Jindal are mutual person
Jindal-Sungshin India Co. Private LimitedActive 1 year 8 monthsRakshit Jindal and Ankit Jindal are mutual person
- Jindal Kim Ventures Private LimitedActive 5 years 9 months
Rakshit Jindal and Ankit Jindal are mutual person
- Hindustan Green Energy LimitedActive 3 years 2 months
Rakshit Jindal and Ankit Jindal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Sep 2023 | ₹11.65 Cr | Open |
Axis Bank Limited Creation Date: 26 Apr 2022 | ₹4.56 M | Open |
Axis Bank Limited Creation Date: 19 Nov 2019 | ₹3.10 M | Open |
How Many Employees Work at Jo Pharma?
Unlock and access historical data on people associated with Jo Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jo Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
